Louise Chen's Stock Ratings

Cantor Fitzgerald Analyst

Louise Chen is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 08/23/2024

Overall Average Return

9.73%

Smart Score

72.3%

Overall Average Return Percentile

59th

Number of Ratings

244
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Key Takeaways From AbbVie Analyst Ratings
A Glimpse Into The Expert Outlook On Novo Nordisk Through 8 Analysts
Beyond The Numbers: 25 Analysts Discuss Eli Lilly Stock
What's Going On With Eli Lilly And Company Shares Wednesday?
Eli Lilly is anticipated to release earnings 2024 fiscal year earnings on Thursday before the market opens.
A Closer Look at 14 Analyst Recommendations For Johnson & Johnson
Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Expert Outlook: Eli Lilly and Co Through The Eyes Of 25 Analysts
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's Q2 FY24 earnings report on August 8 will include a pre-tax IPR&D charge of $154 million, impacting GAAP and non-GAAP EPS by $0.14.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free